Beigene Stock Analysis

BeiGene Stock Analysis Notes

About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 8.19. BeiGene had not issued any dividends in recent years. BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. BeiGene, Ltd. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. Beigene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 8600 people. For more info on BeiGene please contact John Oyler at 345-949-4123 or go to https://www.beigene.com.

BeiGene Investment Alerts

BeiGene Upcoming and Recent Events

BeiGene Largest EPS Surprises

View All Earnings Estimates

BeiGene Environmental, Social, and Governance (ESG) Scores

BeiGene Thematic Classifications

BeiGene Stock Institutional Investors

Note, although BeiGene's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

BeiGene Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 21.23 B.

BeiGene Profitablity

The company has Profit Margin (PM) of (0.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.14.

Management Efficiency

BeiGene has return on total asset (ROA) of (0.0958) % which means that it has lost $0.0958 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2322) %, meaning that it created substantial loss on money invested by shareholders. BeiGene's management efficiency ratios could be used to measure how well BeiGene manages its routine affairs as well as how well it operates its assets and liabilities. As of November 26, 2024, Return On Tangible Assets is expected to decline to -0.16. In addition to that, Return On Capital Employed is expected to decline to -0.32. At present, BeiGene's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 37.5 M, whereas Other Assets are forecasted to decline to 1.90.

Technical Drivers

As of the 26th of November, BeiGene shows the Standard Deviation of 2.46, risk adjusted performance of 0.0037, and Mean Deviation of 1.81. BeiGene technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BeiGene information ratio, as well as the relationship between the value at risk and kurtosis to decide if BeiGene is priced correctly, providing market reflects its regular price of 190.3 per share. Given that BeiGene has information ratio of (0.06), we suggest you to validate BeiGene's prevailing market performance to make sure the company can sustain itself at a future point.

BeiGene Price Movement Analysis

BeiGene Insider Trading Activities

BeiGene Outstanding Bonds

BeiGene Predictive Daily Indicators

BeiGene Corporate Filings

BeiGene Forecast Models

BeiGene's time-series forecasting models are one of many BeiGene's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BeiGene's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how BeiGene prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BeiGene shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BeiGene. By using and applying BeiGene Stock analysis, traders can create a robust methodology for identifying BeiGene entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. BeiGene analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. BeiGene analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

BeiGene stock analysis indicators help investors evaluate how BeiGene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading BeiGene shares will generate the highest return on investment. By understating and applying BeiGene stock analysis, traders can identify BeiGene position entry and exit signals to maximize returns.

When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.